A Clinical Evaluation Of BW430C (Lamotrigine) In Bipolar I Disorder- Long-term Extension Of Study SCA104779 (NCT00550407) -
Status:
Completed
Trial end date:
2010-10-01
Target enrollment:
Participant gender:
Summary
This study is planned to assess the long-term safety of lamotrigine in Japanese patients with
bipolar I disorder who will continue into the 52-week extension upon completion of a
double-blind comparative study (Study No.: SCA104779 (NCT00550407)), i.e. the patients who
receive the addition of any additional treatment to intervene in a mood episode in the
double-blind phase or the patients completing the double-blind phase.